Sign in

CIK 0001590877 · Non-accelerated filer<br>Smaller reporting company

REGENXBIO Inc.

Sign in to watch
Ticker
RGNX
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Entity type
operating
EIN
471851754
Phone
240-552-8181
Business address
9804 MEDICAL CENTER DRIVE, ROCKVILLE, MD, 20850
Former names
ReGenX Biosciences, LLC
  1. 424B5 Offering Prospectus
  2. 424B5 Offering Prospectus
  3. 424B5 Offering Prospectus
  4. CORRESP Other Correspondence Between Filers and SEC Staff
  5. S-3 Offering Registration Statement
  6. 424B3 Offering Prospectus
  7. CORRESP Other Correspondence Between Filers and SEC Staff
  8. UPLOAD Other SEC-generated Letter
  9. S-3 Offering Registration Statement
  10. 424B5 Offering Prospectus
  11. 424B5 Offering Prospectus
  12. 424B5 Offering Prospectus
  13. 424B5 Offering Prospectus
  14. 424B5 Offering Prospectus
  15. 424B5 Offering Prospectus
  16. 424B5 Offering Prospectus
  17. 424B5 Offering Prospectus
  18. S-3 Offering Registration Statement
  19. 424B5 Offering Prospectus
  20. 424B5 Offering Prospectus

Page 1 of 2 · 34 filings